Article
Emerging Pharmacology: Inhibitors of Human Immunodeficiency Virus Integration
17 Oct 2008
Abstract excerpt
The first integrase inhibitor licensed to treat HIV-1 infection was approved in late 2007, more than a decade after the introduction of the first inhibitors of the HIV-1 reverse transcriptase and protease. The unique biochemical and molecular mechanism of action of this novel class of antiretroviral drugs is the fundamental basis for their activity in treating multidrug-resistant HIV-1 infection and is important...
Topics
Join the communities discussing this publication.